XML 38 R26.htm IDEA: XBRL DOCUMENT v3.26.1
Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2026
Accounting Policies [Abstract]  
Schedules of Concentration of Credit Risk Customers that accounted for 10% or greater of accounts receivable, net as of March 31, 2026 and December 31, 2025 were as follows:
March 31,
2026
December 31,
2025
Customer A50%88%
Customer B26%*
*Accounts Receivable was less than 10%
Customers that accounted for equal to or greater than 10% of total revenue were as follows:
Three months ended
March 31,
20262025
Customer A56%*
Customer B19%*
Customer C*31%
Customer D*26%
Customer E*17%
*Less than 10% of total revenue for the period
Schedule of Estimated Fair Value of Convertible Notes Payable Assumptions
The Company calculated the estimated fair value of the convertible notes payable using the following assumptions. No convertible notes were issued during the three months ended March 31, 2026. Accordingly, there were no assumptions used in the determination of fair value for that period.
Three months ended
March 31, 2025
Issuance date2/10/2025
Maturity date2/10/2026
Stock price5.88 
Expected volatility factor124.8 %
Risk-free interest rate4.08 %
Schedules of Changes in Convertible Notes Payable Measured at Fair Value
The following table presents changes in the Level 3 convertible notes payable measured at fair value for the three months ended March 31, 2025 and March 31, 2026 (in thousands):
Balance, January 1, 2025$— 
Additions14,433 
Fair value measurement adjustments10,700 
Balance, March 31, 2025$25,133 
Balance, January 1, 2026$4,518 
Fair value measurement adjustments867 
Gain on extinguishment(326)
Conversion into common stock(5,059)
Balance, March 31, 2026$— 
Schedules of Revenue Disaggregated by Revenue Type
The following table presents the Company’s revenue disaggregated by revenue type (in thousands):
Three months ended
March 31,
20262025
Product related$15,211 $1,630 
Contract related260 — 
Total$15,471 $1,630 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Outstanding securities not included in the computation of diluted net loss per share because their effect would have been anti-dilutive include:
March 31,
2026
December
31, 2025
Series B Preferred Stock, as converted
Stock options4,305 4,701 
Warrants206 583 
Restricted stock2,349 2,124 
Total6,864 7,412